Side effects of glp1 receptor agonists can be nausea, vomiting, and diarrhea
Some physicians combine these approaches for patients who benefit from both appetite control and enhanced fat metabolism, though close medical monitoring is essential
Usual Adult Trulicity Dose for Cardiovascular Risk Reduction: Initial dose: Trulicity 0.75 mg subcutaneously once a week The dose may be increased to 1.5 from 0.75, then in 1.5 mg increments for additional glycemic control
TGA issues warning over GLP-1-based drugs' potential to cause rare eye disorder Fri 24 Jul 2026 at 11:13am In short: The Therapeutic Goods Administration is warning of a rare but serious eye disorder that could be caused by GLP-1-based drugs
Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
Human studies are mixed, though some analyses saw significant weight loss, particularly among obese or older adults, while others saw none